IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Egypt |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Indonesia |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bangladesh |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Russian Federation |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United States of America |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Canada |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
European Union |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Chile |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Australia |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Switzerland |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Japan |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Korea, Republic of |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Bolivia, Plurinational State of |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Norway |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
South Africa |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
Holy See |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
World Health Organization (WHO) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United Nations Conference on Trade and Development (UNCTAD) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
United Nations Conference on Trade and Development (UNCTAD) |
08/11/2016-09/11/2016 |
30/01/2017 |
|
IP/C/M/83, IP/C/M/83/Add.1 |
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines |
World Trade Organization |
08/11/2016-09/11/2016 |
30/01/2017 |
|